CDTX
Price
$65.80
Change
+$1.09 (+1.68%)
Updated
Sep 17, 12:13 PM (EDT)
Capitalization
1.7B
XBIO
Price
$3.22
Change
-$0.01 (-0.31%)
Updated
Sep 17, 03:53 PM (EDT)
Capitalization
4.99M
Interact to see
Advertisement

CDTX vs XBIO

Header iconCDTX vs XBIO Comparison
Open Charts CDTX vs XBIOBanner chart's image
Cidara Therapeutics
Price$65.80
Change+$1.09 (+1.68%)
Volume$100
Capitalization1.7B
Xenetic Biosciences
Price$3.22
Change-$0.01 (-0.31%)
Volume$100
Capitalization4.99M
CDTX vs XBIO Comparison Chart in %
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. XBIO commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Hold and XBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 17, 2025
Stock price -- (CDTX: $64.71 vs. XBIO: $3.23)
Brand notoriety: CDTX and XBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 150% vs. XBIO: 59%
Market capitalization -- CDTX: $1.7B vs. XBIO: $4.99M
CDTX [@Biotechnology] is valued at $1.7B. XBIO’s [@Biotechnology] market capitalization is $4.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileXBIO’s FA Score has 1 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • XBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIO is a better buy in the long-term than CDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 3 TA indicator(s) are bullish while XBIO’s TA Score has 4 bullish TA indicator(s).

  • CDTX’s TA Score: 3 bullish, 4 bearish.
  • XBIO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both CDTX and XBIO are a bad buy in the short-term.

Price Growth

CDTX (@Biotechnology) experienced а +2.78% price change this week, while XBIO (@Biotechnology) price change was +4.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was +6.99%, and the average quarterly price growth was +35.85%.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($1.7B) has a higher market cap than XBIO($4.99M). CDTX YTD gains are higher at: 140.737 vs. XBIO (-18.922). XBIO has higher annual earnings (EBITDA): -3.27M vs. CDTX (-208.92M). CDTX has more cash in the bank: 511M vs. XBIO (4.78M). XBIO has less debt than CDTX: XBIO (153K) vs CDTX (2.33M). XBIO has higher revenues than CDTX: XBIO (2.45M) vs CDTX (0).
CDTXXBIOCDTX / XBIO
Capitalization1.7B4.99M34,015%
EBITDA-208.92M-3.27M6,398%
Gain YTD140.737-18.922-744%
P/E RatioN/AN/A-
Revenue02.45M-
Total Cash511M4.78M10,690%
Total Debt2.33M153K1,525%
FUNDAMENTALS RATINGS
CDTX vs XBIO: Fundamental Ratings
CDTX
XBIO
OUTLOOK RATING
1..100
1719
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
16
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
3445
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XBIO's Valuation (16) in the Biotechnology industry is significantly better than the same rating for CDTX (85). This means that XBIO’s stock grew significantly faster than CDTX’s over the last 12 months.

XBIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CDTX (100). This means that XBIO’s stock grew similarly to CDTX’s over the last 12 months.

CDTX's SMR Rating (97) in the Biotechnology industry is in the same range as XBIO (98). This means that CDTX’s stock grew similarly to XBIO’s over the last 12 months.

CDTX's Price Growth Rating (34) in the Biotechnology industry is in the same range as XBIO (45). This means that CDTX’s stock grew similarly to XBIO’s over the last 12 months.

CDTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as XBIO (100). This means that CDTX’s stock grew similarly to XBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CDTXXBIO
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ICON2.130.01
+0.47%
Icon Energy Corp
CLH235.410.54
+0.23%
Clean Harbors
ENTX1.82-0.01
-0.55%
Entera Bio Ltd
EVCM11.72-0.14
-1.18%
EverCommerce
NAK0.83-0.04
-4.48%
Northern Dynasty Minerals Ltd

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-3.29%
BPTSY - CDTX
92%
Closely correlated
N/A
UNCY - CDTX
51%
Loosely correlated
+1.27%
INDP - CDTX
38%
Loosely correlated
+5.70%
IVVD - CDTX
36%
Loosely correlated
-1.56%
CPRX - CDTX
35%
Loosely correlated
+1.57%
More